BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1359685)

  • 1. Induction of a cell-transferable suppression of alloreactivity by photodamaged lymphocytes.
    Perez MI; Lobo FM; John L; Yamane Y; Edelson RL
    Transplantation; 1992 Nov; 54(5):896-903. PubMed ID: 1359685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA associated with the cell membrane is involved in the inhibition of the skin rejection response induced by infusions of photodamaged alloreactive cells that mediate rejection of skin allograft.
    Perez MI; Yamane Y; John L; Gasparro FP; Edelson RL
    Photochem Photobiol; 1992 Jun; 55(6):839-49. PubMed ID: 1409891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
    Perez M; Edelson R; Laroche L; Berger C
    J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
    Perez MI; Edelson RL; John L; Laroche L; Berger CL
    Yale J Biol Med; 1989; 62(6):595-609. PubMed ID: 2636801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model.
    Perez MI; Berger CL; Yamane Y; John L; Laroche L; Edelson RL
    Transplantation; 1991 Jun; 51(6):1283-9. PubMed ID: 1828639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
    Owens T; Crispe IN
    J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand.
    Markees TG; Phillips NE; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    Transplantation; 1997 Jul; 64(2):329-35. PubMed ID: 9256196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split tolerance induced by orthotopic liver transplantation in mice.
    Dahmen U; Qian S; Rao AS; Demetris AJ; Fu F; Sun H; Gao L; Fung JJ; Starzl TE
    Transplantation; 1994 Jul; 58(1):1-8. PubMed ID: 8036695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of anti-skin-allograft response by photodamaged effector cells--the modulating effects of prednisolone and cyclophosphamide.
    Yamane Y; Lobo FM; John LA; Edelson RL; Perez MI
    Transplantation; 1992 Jul; 54(1):119-24. PubMed ID: 1631919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance of related and unrelated cardiac allografts in neonatally tolerized mice is cardio-specific and transferable by regulatory CD4+ T cells.
    Hofmann B; Tao K; Mai L; West LJ
    J Heart Lung Transplant; 2004 Sep; 23(9):1069-76. PubMed ID: 15454173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
    Coulombe M; Yang H; Wolf LA; Gill RG
    J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J; Schurmans S; Luzuy S; Izui S; Vassalli P; Lambert PH
    J Immunol; 1987 Sep; 139(5):1426-31. PubMed ID: 3114366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.